Summary & Overview
CPT 20550: Tendon or Ligament Injection for Aponeurosis
Headline: CPT code 20550: Therapeutic Tendon or Ligament Injection to Reduce Aponeurosis Formation
Lead: CPT code 20550 denotes a targeted therapeutic injection of a tendon or ligament to address abnormal aponeurotic tissue formation. The code captures a common outpatient musculoskeletal intervention used to relieve symptoms and limit pathological tendon/ligament remodeling.
CPT code 20550 matters nationally because musculoskeletal injections are frequent in outpatient care and affect utilization, billing consistency, and payer coverage policies across commercial and public plans. Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise synthesis of the code’s clinical purpose and service context, common payer coverage patterns, and the operational items relevant to billing and claims adjudication. The publication also outlines typical sites of service and common modifiers used in practice (modifier list provided separately in source data).
The article provides: benchmarks and utilization context for outpatient therapeutic tendon/ligament injections; a summary of payer coverage considerations and variability; and clinical context that clarifies when CPT code 20550 is used versus other musculoskeletal injection codes. Data not available in the input are noted where applicable. The focus is national and intended for billing managers, clinicians involved in procedural coding, and policy analysts tracking procedural utilization.
Billing Code Overview
CPT code 20550 describes an injection of a tendon or ligament intended to treat abnormal sheet-like extensions of tendon tissue (aponeurosis) and reduce aponeurosis formation. This is a therapeutic musculoskeletal injection procedure targeted at tendon or ligament structures.
Service Type: Musculoskeletal therapeutic injection
Typical Site of Service: Outpatient clinic, physician office, or ambulatory surgical center
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A 52-year-old patient presents to an outpatient orthopedic clinic with focal thickening and painful nodular bands along the palmar fascia of the hand, causing impaired finger extension consistent with early Dupuytren contracture and aponeurotic formation. Conservative measures (splinting, NSAIDs) provided limited relief. The orthopedic hand surgeon evaluates the hand, documents range of motion deficits, palpable cords in the palmar fascia, and obtains informed consent for a therapeutic injection to the involved aponeurotic/tendinous region. On the day of service the patient is positioned supine with the arm on an arm board in an outpatient procedure room. The provider prepares sterile field, identifies the targeted aponeurosis by palpation and/or ultrasound guidance, and injects a corticosteroid and/or enzyme agent into the tendon/aponeurosis to reduce inflammation and aponeurotic proliferation. Post-procedure, the site is dressed and the patient is observed briefly for adverse reaction and given written aftercare instructions and a follow-up appointment for reassessment and possible physical therapy referral.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when an E/M visit is performed and documented separately from the injection on the same date. |